Characteristic | All (n = 522) | Male (n = 167) | Female (n = 355) | p value |
---|---|---|---|---|
Age, years | 49.54 (12.06)* | 50.09 (11.25)* | 0.619 | |
Diagnosis | 0.085 | |||
DM | 360 (69) | 126 (75.4) | 234 (65.9) | |
CADM | 47 (9) | 11 (6.6) | 36 (10.1) | |
PM | 115 (22) | 30 (18) | 85 (23.9) | |
OLS | 9 (5.4) | 41 (11.5) | 0.026 | |
Comorbidities | ||||
Diabetes mellitus | 36 (6.9) | 13 (7.8) | 23 (6.5) | 0.583 |
Hypertension | 54 (10.3) | 19 (11.4) | 35 (9.9) | 0.595 |
Chronic hepatitis B | 24 (4.6) | 9 (5.4) | 15 (4.2) | 0.554 |
MDA5+ | 70 (13.4) | 25 (15) | 45 (12.7) | 0.473 |
HB | 130 (120–146) | 121 (109–131) | < 0.001 | |
PLT | 194 (143–254) | 195 (148–262) | 0.508 | |
EO% | 0.6 (0.1–2.6) | 0.7 (0.2–2.4) | 0.653 | |
NLR | 4.52 (3.09–7.82) | 4.25 (2.99–6.84) | 0.323 | |
TBIL | 9 (6.8–12.3) | 8.4 (6.5–11) | 0.042 | |
DBIL | 3.3 (2.5–4.6) | 3 (2.4–3.9) | 0.005 | |
IBIL | 5.2 (4.1–7.8) | 5.5 (4–6.9) | 0.441 | |
TP | 65.2 (59.8–70.5) | 65.9 (61.4–71.1) | 0.147 | |
ALB | 34.9 (31.3–38.4) | 34.3 (30.7–37.9) | 0.272 | |
GLB | 29.8 (25.4–33.7) | 31.7 (27.6–35.9) | 0.002 | |
AST/ALT | 1.12 (0.77–1.56) | 1.30 (1–1.82) | < 0.001 | |
UA/CREA | 5.3 (3.93–6.51) | 5.35 (4.29–7.05) | 0.062 | |
TG | 1.82 (1.35–2.51) | 1.97 (1.45–2.79) | 0.016 | |
LDL | 2.46 (1.81–3.05) | 2.29 (1.68–3) | 0.221 | |
CK | 110 (52–703) | 136 (42–1156) | 0.943 | |
Readmission within 1 year | 36 (21.6) | 67 (18.9) | 0.472 | |
Need for MV within 1 year | 15 (9) | 28 (7.9) | 0.671 | |
Deaths within 1 year | 21 (12.6) | 43 (12.1) | 0.881 |